{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:32:45Z","timestamp":1762083165461,"version":"build-2065373602"},"reference-count":29,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T00:00:00Z","timestamp":1671926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Mucormycosis is a rare fungal infection, with high mortality, commonly associated with diabetes, malignancies, immunosuppressive therapy, and other immunodeficiency conditions. The emergence of mucormycosis cases has been advanced by the COVID-19 pandemic. Clinical presentation is variable, from asymptomatic to persistent fever or localized infections. We present a case of a Romanian old man, without diabetes or other immunodepression, with COVID-19 who developed severe rhino-orbital mucormycosis and bacterial superinfections, with Pseudomonas aeruginosa and Klebsiella pneumoniae. The late diagnostic and antifungal treatment was related to extensive lesions, bone and tissue loss, and required complex reconstruction procedures. We review the relationships between mucormycosis, COVID-19, and bacterial associated infections. The suspicion index of mucormycosis should be increased in medical practice. The diagnostic and treatment of COVID-19-Associated-Mucormycosis is currently challenging, calling for multidisciplinary collaboration.<\/jats:p>","DOI":"10.3390\/antibiotics12010031","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T04:40:39Z","timestamp":1672116039000},"page":"31","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic and Treatment Challenges of Emergent COVID-Associated-Mucormycosis: A Case Report and Review of the Literature"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4762-0755","authenticated-orcid":false,"given":"Manuela","family":"Arbune","sequence":"first","affiliation":[{"name":"Clinical Medical Department, \u201cDunarea de Jos\u201d University from Galati, 800008 Galati, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9500-4498","authenticated-orcid":false,"given":"Anca-Adriana","family":"Arbune","sequence":"additional","affiliation":[{"name":"Neurology Clinic, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Nechifor","sequence":"additional","affiliation":[{"name":"Clinical Medical Department, \u201cDunarea de Jos\u201d University from Galati, 800008 Galati, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iulia","family":"Chiscop","sequence":"additional","affiliation":[{"name":"Clinical Surgical Department, \u201cDunarea de Jos\u201d University from Galati, 800008 Galati, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violeta","family":"Sapira","sequence":"additional","affiliation":[{"name":"Clinical Medical Department, \u201cDunarea de Jos\u201d University from Galati, 800008 Galati, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,25]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Skiada, A., Pavleas, I., and Drogari-Apiranthitou, M. (2020). Epidemiology and Diagnosis of Mucormycosis: An Update. J. Fungi, 6.","key":"ref_1","DOI":"10.3390\/jof6040265"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1007\/s11033-022-07160-3","article-title":"Risks of mucormycosis in the current COVID-19 pandemic: A clinical challenge in both immunocompromised and immunocompetent patients","volume":"49","author":"Monika","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12223-021-00934-5","article-title":"Mucormycosis: Risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic","volume":"67","author":"Sharma","year":"2022","journal-title":"Folia Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"69341","DOI":"10.1007\/s11356-022-22204-8","article-title":"The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: At a glance","volume":"29","author":"Islam","year":"2022","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment","volume":"57","author":"Prakash","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/myc.12884","article-title":"Fungal infections of the central nervous system and paranasal sinuses in on-co-haematologic patients. Epidemiological study reporting the diagnostic-therapeutic approach and outcome in 89 cases","volume":"62","author":"Candoni","year":"2019","journal-title":"Mycoses"},{"doi-asserted-by":"crossref","unstructured":"Prakash, H., and Chakrabarti, A. (2019). Global Epidemiology of Mucormycosis. J. Fungi, 5.","key":"ref_8","DOI":"10.3390\/jof5010026"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"doi-asserted-by":"crossref","unstructured":"Mare\u0219, M., Moroti-Constantinescu, V.R., and Denning, D.W. (2018). The Burden of Fungal Diseases in Romania. J. Fungi, 4.","key":"ref_10","DOI":"10.20944\/preprints201802.0137.v1"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"doi-asserted-by":"crossref","unstructured":"Yasmin, F., Najeeb, H., Naeem, A., Dapke, K., Phadke, R., Asghar, M.S., Shah, S.M.I., De Berardis, D., and Ullah, I. (2021). COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management. Diseases, 9.","key":"ref_12","DOI":"10.3390\/diseases9040065"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: A review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11046-022-00627-8","article-title":"Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis","volume":"187","author":"Watanabe","year":"2022","journal-title":"Mycopathologia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12281-022-00440-2","article-title":"Mortality-Related Risk Factors for Coronavirus Disease (COVID-19)-Associated Mucormycosis: A systematic review and meta-analysis","volume":"16","author":"Ostovan","year":"2022","journal-title":"Curr. Fungal Infect. Rep."},{"doi-asserted-by":"crossref","unstructured":"Hussain, S., Riad, A., Singh, A., Klugarov\u00e1, J., Antony, B., Banna, H., and Klugar, M. (2021). Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis. J. Fungi, 7.","key":"ref_16","DOI":"10.3390\/jof7110985"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/ijp.ijp_839_21","article-title":"COVID-19-Associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis","volume":"53","author":"Bhattacharyya","year":"2021","journal-title":"Indian J. Pharmacol."},{"doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Carnero, L.C., and Mora-Montes, H.M. (2022). Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis. J. Fungi, 8.","key":"ref_18","DOI":"10.3390\/jof8050445"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.puhe.2021.05.028","article-title":"COVID-19, corticosteroids and public health: A reappraisal","volume":"197","author":"Fernandes","year":"2021","journal-title":"Public Heal."},{"doi-asserted-by":"crossref","unstructured":"Sharma, R., Kumar, P., Rauf, A., Chaudhary, A., Prajapati, P.K., Emran, T.B., Lima, C.M.G., and Conte-Junior, C.A. (2022). Mucormycosis in the COVID-19 Environment: A Multifaceted Complication. Front. Cell. Infect. Microbiol., 12.","key":"ref_20","DOI":"10.3389\/fcimb.2022.937481"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/jim-2022-002362","article-title":"Hepcidin, iron, and COVID-19: Is there an erythroid connection?","volume":"70","author":"Means","year":"2022","journal-title":"J. Investig. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/alr.22906","article-title":"In-hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID-19) patients and COVID-19 in mucormycosis: A systematic review and meta-analysis","volume":"12","author":"Sinha","year":"2021","journal-title":"Int. Forum Allergy Rhinol."},{"doi-asserted-by":"crossref","unstructured":"Fourie, R., and Pohl, C.H. (2019). Beyond Antagonism: The Interaction between Candida Species and Pseudomonas aeruginosa. J. Fungi, 5.","key":"ref_23","DOI":"10.3390\/jof5020034"},{"doi-asserted-by":"crossref","unstructured":"Phuengmaung, P., Mekjaroen, J., Saisorn, W., Chatsuwan, T., Somparn, P., and Leelahavanichkul, A. (2022). Rapid Synergistic Biofilm Production of Pseudomonas and Candida on the Pulmonary Cell Surface and in Mice, a Possible Cause of Chronic Mixed Organismal Lung Lesions. Int. J. Mol. Sci., 23.","key":"ref_24","DOI":"10.3390\/ijms23169202"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-42175-0","article-title":"Pseudomonas aeruginosa inhibits Rhizopus microsporus germination through sequestration of free environmental iron","volume":"9","author":"Kousser","year":"2019","journal-title":"Sci. Rep."},{"doi-asserted-by":"crossref","unstructured":"Bergeron, A.C., Seman, B.G., Hammond, J.H., Archambault, L.S., Hogan, D.A., and Wheeler, R.T. (2017). Candida albicans and Pseudomonas aeruginosa Interact to Enhance Virulence of Mucosal Infection in Transparent Zebrafish. Infect. Immun., 85.","key":"ref_26","DOI":"10.1128\/IAI.00475-17"},{"doi-asserted-by":"crossref","unstructured":"Smith, C., and Lee, S.C. (2022). Current treatments against mucormycosis and future directions. PLoS Pathog., 18.","key":"ref_27","DOI":"10.1371\/journal.ppat.1010858"},{"doi-asserted-by":"crossref","unstructured":"Lamoth, F., Lewis, R.E., and Kontoyiannis, D.P. (2020). Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections. J. Fungi, 7.","key":"ref_28","DOI":"10.3390\/jof7010017"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/myc.13420","article-title":"Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID-19-Associated mucormycosis in a real-life setting","volume":"65","author":"Patel","year":"2021","journal-title":"Mycoses"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/1\/31\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:50:49Z","timestamp":1760147449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/1\/31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,25]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["antibiotics12010031"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics12010031","relation":{},"ISSN":["2079-6382"],"issn-type":[{"type":"electronic","value":"2079-6382"}],"subject":[],"published":{"date-parts":[[2022,12,25]]}}}